CD4 and neoplasm: Previous studies have reported that several immunogenic microenvironment factors, such as T cells (CD4+) (Du et al., 2018), macrophages (Zappasodi et al., 2018), and mast cells (Somasundaram et al., 2021), are prognostic and predictive markers in many tumor types.